AGUENNOUZ, M'hammed
 Distribuzione geografica
Continente #
EU - Europa 14.148
NA - Nord America 13.790
AS - Asia 7.048
SA - Sud America 2.546
Continente sconosciuto - Info sul continente non disponibili 499
AF - Africa 287
OC - Oceania 11
AN - Antartide 1
Totale 38.330
Nazione #
US - Stati Uniti d'America 13.380
RU - Federazione Russa 6.805
SG - Singapore 3.059
BR - Brasile 2.194
CN - Cina 2.010
IE - Irlanda 1.587
IT - Italia 1.398
SE - Svezia 1.357
DE - Germania 751
HK - Hong Kong 707
UA - Ucraina 515
FR - Francia 488
FI - Finlandia 416
VN - Vietnam 401
GB - Regno Unito 303
IN - India 185
PL - Polonia 179
CA - Canada 164
AR - Argentina 118
BD - Bangladesh 105
BE - Belgio 76
IQ - Iraq 70
MX - Messico 70
TR - Turchia 69
EC - Ecuador 67
ZA - Sudafrica 67
AT - Austria 58
ID - Indonesia 54
NL - Olanda 52
CO - Colombia 50
IL - Israele 47
PK - Pakistan 47
JP - Giappone 45
MA - Marocco 45
UZ - Uzbekistan 45
CI - Costa d'Avorio 42
CR - Costa Rica 38
VE - Venezuela 36
CZ - Repubblica Ceca 33
CL - Cile 30
SC - Seychelles 29
ES - Italia 28
KE - Kenya 24
TN - Tunisia 23
AZ - Azerbaigian 21
PY - Paraguay 21
HN - Honduras 20
SA - Arabia Saudita 20
EG - Egitto 18
JM - Giamaica 18
KZ - Kazakistan 17
MY - Malesia 17
NP - Nepal 17
GT - Guatemala 16
NI - Nicaragua 16
LT - Lituania 15
PE - Perù 15
PR - Porto Rico 15
DZ - Algeria 14
IR - Iran 13
PH - Filippine 13
SV - El Salvador 13
LB - Libano 12
AL - Albania 11
TT - Trinidad e Tobago 11
AE - Emirati Arabi Uniti 10
CW - ???statistics.table.value.countryCode.CW??? 9
DO - Repubblica Dominicana 9
PT - Portogallo 9
UY - Uruguay 9
EU - Europa 8
AU - Australia 7
KG - Kirghizistan 7
OM - Oman 7
RO - Romania 7
TH - Thailandia 7
BG - Bulgaria 6
BO - Bolivia 6
JO - Giordania 6
PS - Palestinian Territory 6
RS - Serbia 6
SN - Senegal 6
CH - Svizzera 5
EE - Estonia 5
GP - Guadalupe 5
GR - Grecia 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
AM - Armenia 4
BB - Barbados 4
KH - Cambogia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
GA - Gabon 3
HR - Croazia 3
KR - Corea 3
LV - Lettonia 3
Totale 37.798
Città #
Moscow 2.072
Ashburn 1.885
Dublin 1.586
Singapore 1.526
Dallas 1.390
Chandler 1.092
Jacksonville 1.067
San Jose 863
Nyköping 830
Beijing 722
Hong Kong 707
Council Bluffs 474
The Dalles 382
Messina 363
Los Angeles 314
Princeton 300
Medford 273
Munich 251
Lauterbourg 246
Cambridge 245
Ann Arbor 241
Des Moines 213
Dearborn 172
São Paulo 164
Warsaw 157
New York 146
Buffalo 135
Ho Chi Minh City 130
Boardman 129
Helsinki 91
Santa Clara 89
Tianjin 89
Rome 83
Jinan 82
Wilmington 80
Shenyang 75
Hanoi 72
Rio de Janeiro 70
Brooklyn 69
Brussels 67
Phoenix 67
Lancaster 66
San Mateo 66
Turku 66
Woodbridge 64
Frankfurt am Main 61
Redondo Beach 61
Guangzhou 60
Orem 60
Belo Horizonte 59
Houston 49
Hyderabad 49
Nanjing 49
Atlanta 47
Bremen 44
Abidjan 41
Milan 41
Curitiba 40
Tashkent 40
Tokyo 40
Vienna 40
Montreal 39
Shanghai 39
Pune 38
Seattle 38
Hebei 36
Columbus 35
Nuremberg 35
Brasília 32
London 32
Porto Alegre 32
Chicago 30
Ningbo 30
Catania 29
Johannesburg 29
Chennai 28
Salvador 28
Toronto 28
Zhengzhou 28
Hangzhou 27
Norwalk 27
Taizhou 27
Caltagirone 26
Denver 26
Haikou 26
Quito 25
San José 25
Campinas 24
Dong Ket 24
Guarulhos 24
Guayaquil 24
Ottawa 24
Nairobi 23
Palermo 23
San Francisco 23
Amsterdam 22
Baghdad 22
Baku 21
Falls Church 21
Mumbai 21
Totale 21.143
Nome #
Idrocefalo normoteso idiopatico (iNPH): nostra esperienza preliminare. 472
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 377
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 346
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. 279
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 270
4-Methyl umbelliferone effects on cell proliferation in human glioma cells. 267
Clinical and pathological features of focal myositis 258
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 254
MiRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma 252
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 244
A Nouvel serum MicroRNA signature to screen ATTR 241
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury 235
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 231
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 229
A cytochemical study of apoptosis in metabolic myopathies 218
A life threatening case of β-enolase deficiency 215
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 214
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 213
A homozygous MED11 C-terminal variant causes a lethal neurodegenerative disease 212
microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors 211
miRNA regulation of Sirtuin-1 expression in human astrocytoma 207
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 203
Effect of exercise on telomere length and telomere proteins expression in mdx mice 202
(+)-Lipoic Acid Reduces Lipotoxicity and Regulates Mitochondrial Homeostasis and Energy Balance in an In Vitro Model of Liver Steatosis 202
Hippo signaling pathway is altered in Duchenne muscular dystrophy 200
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 198
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 198
Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity 195
Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study 195
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 194
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 194
A case of vacuolar myopathy during the course of chronic hepatitis C. 193
A novel variant of GALC in a familial case of Krabbe disease: Insights from structural bioinformatics and molecular dynamics simulation 191
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 191
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 190
ANT1 is reduced in sporadic inclusion body myositis. 188
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 187
Role of inflammation and oxidative stress mediators in gliomas. 186
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 185
Analysis of lipid profile in lipid storage myopathy 185
Pilot study of flavocoxid in ambulant DMD patients. 182
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 179
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 179
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 178
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 178
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 177
Type I Hyperprolinemia Associated with Epilepsy and Mental Retardation Results from PRODH Gene Mutations in Three Sicilian Children. 176
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 176
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 176
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 175
Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. 175
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 174
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 174
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 170
Ant1 expression and RAGE-NF-kB pathway activation in sporadic inclusion body myositis 169
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 169
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 169
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 168
A rare PANK2 deletion in the first north African patient affected with pantothenate kinase associated neurodegeneration 166
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 163
Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome 162
Expression of telomeric repeat binding factor-1 in astroglial bran tumors 161
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 161
Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination 161
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 161
Pilot study of flavocoxid in ambulant DMD patients. 161
Meccanismi anti-apoptotici nei gliomi. Ruolo dell'attività nucleare del nuclear factor-kb e dei suoi fattori di controllo. 159
Pilot study of flavocoxid in ambulant DMD patients. 159
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 159
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 158
Fatal R631C mutation is also present in the adult form of CPTII deficiency 158
Miopatie metaboliche 158
Severe rhabdomyolysis in a patient with “Heat Stroke” 158
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 157
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 157
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination 157
Meccanismi antiapoptotici nf-kb-mediati in gliomi umani in vivo. 156
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 156
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 156
Matrix Metalloproteinase 9 and Transglutaminase 2 Expression at the Ocular Surface in Patients with Different Forms of Dry Eye Disease 153
Sarcoglycans in cerebral cortex of the rat: an immunohistochemical and molecular study. 152
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors 151
Evidence of calpain and caspase-3-like activation in CSF of severe human traumatic brain injury 150
Calpain 3 deficiency in Quail Eater's disease 149
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 148
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 146
Inverse correlation between TRF-1 (telomeric-repeat binding factor 1) and histological grade of malignant brain tumors 144
Meccanismi antiapoptotici NF-kB-mediati in gliomi umani in vivo. 144
Implication of SIRT1 and its downstream pathways in dystrophic process. 144
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 143
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 143
Espressione del telomeric Repeat Binding Factor-1 (TRF-1) nei tumori cerebrali della serie astrogliale: possibili implicazioni clinico-terapeutiche. 143
Novel SHOX Gene Mutation in a Short Boy with Becker Muscular Dystrophy: Double Trouble in Two Adjacent Genes. 141
Differential expression of Hippo signaling pathway in human astroglial tumors 141
Association between osteocalcin and residual β-cell function in children and adolescents newly diagnosed with type 1 diabetes: a pivotal study 141
Expression of the trascription factor NFkB in different muscular dystrophies 140
study of flavocoxid in ambulant DMD patients. 139
Meningiomas and proteomics: Focus on new potential biomarkers and molecular pathways 138
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 135
Blood Neurofilament Light Chain and Phospho-Tau 181 in Subjects with Mild Cognitive Impairment Due to Age-Related Hearing Loss 135
Totale 18.630
Categoria #
all - tutte 130.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.923


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.498 0 0 0 0 96 27 138 83 35 234 238 647
2022/20234.491 372 381 232 322 348 423 72 258 1.907 17 107 52
2023/20241.197 90 186 77 92 119 220 37 79 12 92 27 166
2024/20255.938 108 61 114 333 283 184 148 1.318 1.406 354 607 1.022
2025/202616.552 872 1.236 1.423 1.165 1.199 3.545 2.090 1.870 1.965 667 293 227
2026/20272.994 257 678 756 1.148 155 0 0 0 0 0 0 0
Totale 38.330